SynthesisJournal of diabetes research2026

Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World Clinical and Economic Outcomes.

Abdulgafar Olayiwola Jimoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.